| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01EX09 | B | Nintedanib - 150mg | 8524 | 161315/1 | OFEV | 150mg | 60 | Capsule, soft | Oral | Mersaco | Boehringer Ingelheim Pharma GmbH & Co KG | Germany | 209,943,960 L.L | 2.44 | E2 | Boehringer Ingelheim International GmbH | Germany | 6/3/2026 |
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01EX09 | G | Nintedanib - 150mg | 12595 | 27426/1 | NINTAVA | 150mg | 60 | Capsule | Oral | Levant Pulse SARL | Manufactured Qilu Pharmaceutical Co Ltd, China Packed by Alfa Laboratoires S.A.L. | Lebanon | 138,064,938 L.L | 2.44 | E2 | Alfa Laboratoires S.A.L. | Lebanon | 6/3/2026 | |
| L01EX09 | B | Nintedanib - 150mg | 8524/388 | 161315/1 | OFEV | 150mg | 60 | Capsule, soft | Oral | Mersaco | Boehringer Ingelheim Pharma GmbH & Co KG | Germany | L.L | 2.44 | E2 | Boehringer Ingelheim International GmbH | Germany | 6/3/2026 |
